Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.1K Hold
235
– – 0.05% 111
2026
Q1
$82.7K Hold
235
– – 0.05% 105
2025
Q4
$76.9K Hold
235
– – 0.05% 108
2025
Q3
$66.3K Hold
235
– – 0.04% 107
2025
Q2
$65.6K Hold
235
– – 0.05% 107
2025
Q1
$73.2K Sell
235
-220
-48% -$65K 0.05% 100
2024
Q4
$119K Hold
455
– – 0.08% 89
2024
Q3
$147K Sell
455
-25
-5% -$8.18K 0.1% 78
2024
Q2
$150K Hold
480
– – 0.11% 80
2024
Q1
$136K Buy
+480
New +$140K 0.1% 88

Other funds holding AMGN

Pingora Partners's AMGN Position: Q2 2026 in Review

Pingora Partners held its Amgen (AMGN) position steady in Q2 2026 at 235 shares worth $85.1K. The position accounts for 0.05% of the portfolio, ranked #111.

Pingora Partners first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $150K in Q2 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pingora Partners held 235 shares of Amgen worth $85.1K as of Q2 2026.
  • Pingora Partners left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Pingora Partners's portfolio in Q2 2026, its #111 holding.
  • Pingora Partners first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Pingora Partners's Amgen position peaked at $150K in Q2 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.